<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Athersys’ adult allogeneic stem cell IND gets OK from FDA</title>
	<atom:link href="http://regeneration-station.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/feed/" rel="self" type="application/rss+xml" />
	<link>http://regeneration-station.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/</link>
	<description>Stem cells, biomaterials, engineered tissues, and other cell-based technologies.  The guts of the Regenerative Medine industry.</description>
	<lastBuildDate>Thu, 27 Oct 2011 11:43:42 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Athersys’ Adult Stem Cell Product IND Approved for Acute MI Phase I Trial &#171; The Regeneration Station</title>
		<link>http://regeneration-station.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/#comment-11</link>
		<dc:creator><![CDATA[Athersys’ Adult Stem Cell Product IND Approved for Acute MI Phase I Trial &#171; The Regeneration Station]]></dc:creator>
		<pubDate>Sun, 23 Dec 2007 17:06:52 +0000</pubDate>
		<guid isPermaLink="false">http://regenerationstation.wordpress.com/2007/11/20/athersys%e2%80%99-adult-allogeneic-stem-cell-ind-gets-ok-from-fda/#comment-11</guid>
		<description><![CDATA[[...] Posts Athersys’ adult allogeneic stem cell IND gets OK from FDAPfizer Launches Independent BioInnovation CenterThe Regenerative Medicine Industry Job Search - [...]]]></description>
		<content:encoded><![CDATA[<p>[...] Posts Athersys’ adult allogeneic stem cell IND gets OK from FDAPfizer Launches Independent BioInnovation CenterThe Regenerative Medicine Industry Job Search &#8211; [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

